Skip to Main ContentSkip to Search
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks
Updated July 16, 2026, 11:47 am EDT / Original July 15, 2026, 5:54 pm EDT
Share
Add us on Google
Choose Barron's as a preferred source of financial news
Resize
Reprints
In this article
Key Points
About This Summary
-
UnitedHealth Group stock jumped after the company reported second-quarter adjusted earnings of $6.38 a share, beating analyst estimates of $4.91.
-
The healthcare giant raised its full-year adjusted earnings outlook to a range of $19.50 to $20 a share, up from its previous floor of $18.25.
-
UnitedHealth’s medical-cost ratio fell to 86.7% for the quarter, down from 89.4% last year and better than the 88.4% Wall Street expected.
UNH\ \ +1.16% Group stock spiked on Thursday after the healthcare giant posted second-quarter earnings that handily topped analyst projections and raised its guidance. But one number—the so-called medical-cost ratio—is doing the heavy lifting.
UnitedHealth posted adjusted earnings of $6.38 a share, outstripping analysts’ calls for $4.91. Revenue rose slightly to $112 billion, beating out the $110.8 billion Wall Street had expected.
On the back of its latest quarter, UnitedHealth boosted its full-year adjusted earnings outlook to a range of $19.50 to $20 a share, up from a previous floor of $18.25. Analysts were looking for $18.49 a share.
The company’s medical-cost ratio—the percentage of insurance premiums paid out to cover medical expenses—was 86.7% for the quarter, down from 89.4% last year and better than the 88.4% Wall Street had anticipated (a lower number means the company is keeping more of its premiums). Management credited the improvement to “product design changes, improved medical management, and better aligned pricing.”
Advertisement - Scroll to Continue
UnitedHealth stock was up nearly 8% Thursday morning. Shares of other players in the Medicare Advantage market were also getting a lift: Humana
HUM\ \ -5.22% and CVS Health, which operates insurer Aetna, both gained about 1% after the market opened.
The Medicare Advantage program for seniors’ healthcare is a key business for UnitedHealth—and higher costs in that market tripped up the insurance giant last year. UnitedHealth Group’s stock fell hard in 2025.
On Thursday, investors were eager for confirmation that medical spending trends were in hand for a second quarter in a row, following positive first-quarter results. Shares are up nearly 27% so far in 2026, as of Wednesday’s close.
Advertisement - Scroll to Continue
“A strong 2Q was widely expected and this should be good enough to keep the rally going,” Raymond James analyst John Ransom wrote Thursday after the earnings announcement.
UnitedHealth has scaled back its Medicare footprint to improve margins. The company now expects full-year enrollment in its Medicare Advantage plans to decline by about 1.1 million beneficiaries.
“Medical cost trends in Medicare are still running well above historical levels, but below our expectations so far in 2026,” said Tim Noel, CEO of the company’s UnitedHealthcare insurance business, on an investor call. He credited company initiatives such as redesigning benefits and care management models.
“Overall, UNH’s momentum exiting 2Q26 appears quite strong,” wrote Wells Fargo analyst Stephen Baxter.
Write to Catherine Dunn at catherine.dunn@dowjones.comExternal link and Mackenzie Tatananni at mackenzie.tatananni@barrons.comExternal link
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Chart of the Week: Talen Energy's Bull Run Is Just Getting Started \
\
0·9 hours ago\
\
